日本語 
Pharma
Aisin Corporation and JEOL Ltd. have jointly developed a portable bulk compact NMR system that brings nuclear magnetic resonance analysis closer to where research actually happens. This setup does not…
Nxera Pharma to Get $10M from AbbVie for Neuro Project
Nxera Pharma Co., Ltd. has announced the achievement of a significant second…
FerroptoCure Inc Concludes Series A Round
Tokyo biotech startup FerroptoCure has raised ¥460 million in Series A funding.…
FUJIFILM and argenx Extend Collaboration to U.S. Operations
FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding…
Rohto Pharma Builds Global Platform with Dynamics 365
Hitachi Solutions, Ltd. has implemented Microsoft Dynamics 365 at Rohto Pharmaceutical Co.,…
Hitachi and KSK Team Up on Pharma Delivery Digitalization
KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to…
Eisai seeks FDA approval for LEQEMBI Subcutaneous dose
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Eisai’s Tazemetostat Approved as Orphan Drug in Japan
Eisai Co., Ltd. announced that it has received orphan drug designation for…
Nxera Pharma to Get $10M from AbbVie for Neuro Project
Nxera Pharma Co., Ltd. has announced the achievement of a significant second…
FerroptoCure Inc Concludes Series A Round
Tokyo biotech startup FerroptoCure has raised ¥460 million in Series A funding.…
FUJIFILM and argenx Extend Collaboration to U.S. Operations
FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding…
Rohto Pharma Builds Global Platform with Dynamics 365
Hitachi Solutions, Ltd. has implemented Microsoft Dynamics 365 at Rohto Pharmaceutical Co.,…
Hitachi and KSK Team Up on Pharma Delivery Digitalization
KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to…
Eisai seeks FDA approval for LEQEMBI Subcutaneous dose
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Eisai’s Tazemetostat Approved as Orphan Drug in Japan
Eisai Co., Ltd. announced that it has received orphan drug designation for…
English